Mon, Jul 24, 2017 | updated 12:13 AM IST

Non-invasive gene therapy could treat brain tumour

Updated: Jul 23, 2016 10:55 IST      
Non-invasive gene therapy could treat brain tumour

Washington, July 23 (ANI): A team of researchers at the University of Massachusetts Medical School, led by an Indian neuroscientist, has developed a non-invasive gene therapy to treat brain tumour.

Currently, treatment for brain tumour or Gliobastoma (GBM) involves surgery, followed by radiation and chemotherapy with temozolomide.

Still, complete surgical removal of tumour is nearly impossible, as these cells are also radio and chemotherapy resistant.

Thus, tumour recurs in a few months after surgery and finally causes death. Even with the best of treatment, only 3% patients survive up to five years.

One of the major difficulties to treat glioblastoma is the tumour cells are highly migratory and they travel long distances within the brain as single cell infiltrates and invades within other tissues.

These single cell infiltrations are difficult to detect in the MRI scan and also almost indistinguishable from healthy tissues in the brain. Thus, it is impossible to remove the tumour completely in a surgery.

Since the overall survival of a GBM patient post diagnosis is less than two years, medical scientists have been exploring therapeutic approaches to prevent recurrence of tumour.

According to a report appearing in the Indian Science Journal, a team of scientists led by Dwijit Guha Sarkar of University of Massachusetts Medical School researched the possibility of such an approach and found a systemic delivery approach of viral vector mediated gene therapy injection in the blood, with Interferon beta (IFNb) gene. IFNb is a cytokine secreted from cells upon viral infection and activates several genes downstream.

IFNb is a cytokine, which is a class of secreted proteins that play important immune functions in our body. IFNb is naturally secreted from our body cells as a part of immune protective mechanism when there is a viral infection. It can modulate ~300 other gene expressions downstream and can activate many biochemical pathways.

Interestingly, other than its role as immune-modulator, it has several anti-tumour functions. It can inhibit cancer cell division, prevents new blood vessel formation (angiogenesis) in tumour, can also sensitize some chemo-resistant tumour cells to some chemotherapeutic drugs.

"In search for a new therapeutic approach, in this study we examined (in a mouse model) a method of gene therapy. We have implanted highly invasive and aggressive human glioblastoma tumour cells in the mouse brain. We allowed it to graft and grow. Then we treated these animals with our new gene therapy approach. We have used adeno-associated viral vector (AAV) mediated interferon-beta (IFNb) gene therapy, GuhaSarkar told Indian Science Journal.

Gene therapy involves supplementing, silencing, correcting, or providing with genes having therapeutic benefit. Traditionally, gene therapy is a strategy most commonly being tested for treatment of single gene disorders, where a single non-functioning or bad (mutated) gene is responsible for the disease. Gene therapy strategy usually supplements the body with a good version of the gene or silences a gene producing toxic proteins. More recently, a new approach of gene therapy is also attempting to correct the bad gene by editing the genome - the complete set of genetic material present in a cell of a host organism, instead of just supplementing or silencing.

Scientists have tested different gene therapy approaches to treat cancers. But glioblastoma and many other cancers are often caused by abnormal functioning of multiple genes that involve a complex pathological mechanism, which is still be completely understood. So, simply supplementing, silencing or editing one gene is not sufficient to treat these cancers.

Therefore, scientists needed to take different approaches. One of them is to deliver some genes to the cancer cells, where the genes express proteins that can directly or through activating a drug can kill the same cancer cells that are producing that protein. Those genes are called "suicidal genes" as they kill the same cells where they are produced. If gene delivery can be done specifically and efficiently to the cancer cells, minimizing the suicidal gene transfer to the healthy normal cells, this approach could be promising. But often gene delivery to cancer cells is a very inefficient process and difficult to achieve specific targeting. Hence, only some cancer cells that receive the suicide genes die, but many cells escape the treatment, which causes recurrence of tumour.

"We found that this treatment was effective in a dose-responsive manner and an optimum dose could completely eliminate the highly invasive tumour from mouse brain and provided long term survival benefit. At the end of the study, we analyzed the brain microscopically using tissue and tumour staining where could not detect any remaining or recurring tumour in the treated animals, added Dr. GuhaSarkar. "We also found this intravenous delivery approach (injecting in the blood) was far superior to local treatment approach for treating a condition with multiple distant tumours."

GuhaSarkar said, the result of the current study is very exciting and demonstrates a promising new approach. But, there are a few more challenges that have to be addressed before moving on to human trials. One of them is that, these mice used for human tumour grafting were for obvious reasons immune-compromised, so they don't reject the human-origin cells. But body's immune system interacts with the tumour in a complex mechanism and plays important role in tumour prognosis. Moreover, IFNb as a molecule has immune-modulatory role when expressed in the species-matched host.

Human IFNb over-expression in human body can potentially have detrimental side effects unless expressed in a regulated manner. Hyper-activation of immune system by continuous expression of IFNb could also have possible toxic effects in the long term unless the expression can be switched off when it is not needed anymore. These issues have to be taken care of before this approach can be successfully replicated in human beings.

GuhaSarkar is an alumnus of the University of Calcutta and plan to take up post-doctoral research in Bose Institute, Kolkata after his current research under the guidance of Dr. Miguel Sena-Esteves at University of Massachusetts Medical School. (ANI)

Genetic variation may increase tuberculosis susceptibility

Updated: Jul 23, 2017 10:53 IST     

Washington D.C. [USA], July 23 (ANI): Chinese researchers have found that a single change in a gene may increase the risk of tuberculosis.

Full Story >>

This is your brain on depression

Updated: Jul 22, 2017 13:55 IST     

Washington D.C. [USA], July 22 (ANI): Got the blues? According to a recent study, depression can change the structure of your brain.

Full Story >>

Rush-hour pollution may be more harmful than thought

Updated: Jul 22, 2017 10:57 IST     

Washington D.C. [USA], Jul 22 (ANI): Turns out, rush-hour commuters may be in for a double whammy of pollution exposure.

Full Story >>

TRAC, MedGenome announce Cancer Immunotherapy solution

Updated: Jul 22, 2017 06:24 IST     

New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.

Full Story >>

Are some people genetically programmed to be depressed?

Updated: Jul 21, 2017 09:48 IST     

Washington D.C. [USA], Jul 21 (ANI): It's a sombre thought, but it seems that some of us are born more likely to be depressed.

Full Story >>

Washington D.C. [USA], Jul 21 (ANI): A team of researchers has come up with a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests.

Full Story >>

Ahmedabad (Gujarat) [India], July 21 (ANI): Ayurveda is a form of alternative medicine which seeks to treat and integrate body, mind and spirit using a comprehensive holistic approach especially by emphasizing diet, herbal remedies, exercise, meditation, breathing, and physical therapy.

Full Story >>

Washington D.C. [USA], Jul 20 (ANI): When it comes to faring well after chemotherapy, a cancer patient's social interaction matters, according to a recent study.

Full Story >>

New radiotherapy find offers hope to cancer patients

Updated: Jul 20, 2017 10:06 IST     

Washington D.C. [USA], Jul 20 (ANI): An exciting discovery in the cancer treatment is having dramatic results.

Full Story >>

New strategy could yield more effective flu shots

Updated: Jul 20, 2017 09:46 IST     

Washington D.C. [USA], Jul 20 (ANI): A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a recent study.

Full Story >>

Revealed! Best time to sleep to wake up feeling refreshed

Updated: Jul 20, 2017 04:09 IST     

London [UK], July 20 (ANI): The secret of a good night's sleep has finally been unveiled!

Full Story >>

Anxiety drug may help you with fear of social rejection

Updated: Jul 19, 2017 14:22 IST     

Washington D.C. [USA], July 19 (ANI): A team of researchers has found that low doses of anxiety disorder-reducing drug can help highly-anxious people overcome their fear of being over-looked and rejected socially.

Full Story >>

Washington D.C. [USA], July 19 (ANI): Good news! A new technology may help to non-invasively predict children or newborn at risk of an asthma attack.

Full Story >>

Your poor sleep may increase risk of Alzheimer's: Study

Updated: Jul 19, 2017 10:08 IST     

Washington D.C. [USA], July 19 (ANI): Beware! Breathing problems during sleep may be a signal of an increased risk for Alzheimer's disease, warns a study.

Full Story >>

Indian population, carrier of hepatitis B: Study

Updated: Jul 18, 2017 20:01 IST     

New Delhi [India], July 18 (ANI): Viral hepatitis is inflammation and damage of the liver by viruses , most commonly hepatotrophic (predominantly with an affinity for attacking the liver - Hepatitis A , B , C , D , E ) or non hepatotrophic viruses (Generalized involvement of human body with liver as a target tissue seen with Dengue virus , Chikungunya etc.).

Full Story >>

This monsoon, let's be HepAware!

Updated: Jul 18, 2017 18:01 IST     

New Delhi [India], July 18 (ANI): Hepatitis A is mild to the moderate viral disorder of the liver which is affected by the consumption of contaminated food and water. Unfortunately, monsoons are the best time when air/water borne infections are at its peak.

Full Story >>

Washington D.C. [USA], July 18 (ANI): If your grandparents are suffering from dementia, then you can help them by interacting with them about their interests for an hour a week and improve their quality life.

Full Story >>

New Delhi [India], July 17 (ANI): Commemorating its 21st Founder's Day and in an endeavor to promote healthy lifestyle, Pushpawati Singhania Hospital & Research Institute (PSRI) a multi-specialty hospital here organized free health check-up camps and school wellness programme.

Full Story >>

Here's how weekly social hour can help dementia patients

Updated: Jul 17, 2017 11:49 IST     

Washington D.C. [USA], Jul 17 (ANI): Person-centred activities combined with just one hour a week of social interaction can improve quality of life and reduce agitation for people with dementia living in care homes, while saving money, according to a recent study.

Full Story >>

Combo therapy better than drug alone against Alzheimer's

Updated: Jul 17, 2017 11:34 IST     

Washington D.C. [USA], Jul 17 (ANI): Combining a specific care management program with a commonly-prescribed drug for Alzheimer's disease is better at turning back the clock on the ageing brain than medication alone, according to a recent study.

Full Story >>